• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.

作者信息

Peng Pai, Hu Jie, Deng Hai-Jun, Liu Bei-Zhong, Fang Liang, Wang Kai, Tang Ni, Huang Ai-Long

机构信息

Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Yong-Chuan Hospital, Chongqing Medical University, Chongqing, 402160, China.

出版信息

Cell Mol Immunol. 2021 Feb;18(2):490-491. doi: 10.1038/s41423-020-00605-4. Epub 2021 Jan 8.

DOI:10.1038/s41423-020-00605-4
PMID:33420358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7791534/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e2c/9427982/eec16d0be020/41423_2020_605_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e2c/9427982/eec16d0be020/41423_2020_605_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e2c/9427982/eec16d0be020/41423_2020_605_Fig1_HTML.jpg

相似文献

1
Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.8个月内新冠康复患者体液免疫反应的变化。
Cell Mol Immunol. 2021 Feb;18(2):490-491. doi: 10.1038/s41423-020-00605-4. Epub 2021 Jan 8.
2
Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.评估 SARS-CoV-2 免疫在康复期儿童和青少年中的作用。
Front Immunol. 2021 Dec 17;12:797919. doi: 10.3389/fimmu.2021.797919. eCollection 2021.
3
Clinical and immunological characteristics in COVID-19 convalescent patients.新型冠状病毒肺炎（COVID-19）康复患者的临床和免疫学特征。
Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2669-2676. doi: 10.1007/s10096-021-04360-w. Epub 2021 Oct 9.
4
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.COVID-19 恢复期患者体内 SARS-CoV-2 抗体动态变化和 B 细胞记忆应答特征。
Clin Microbiol Infect. 2021 Sep;27(9):1349.e1-1349.e6. doi: 10.1016/j.cmi.2021.05.008. Epub 2021 May 8.
5
Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months.COVID-19 患者从住院到康复后六个月内 SARS-CoV-2 诱导的体液免疫反应的可持续性。
Virol Sin. 2021 Oct;36(5):869-878. doi: 10.1007/s12250-021-00360-4. Epub 2021 Mar 4.
6
The known unknowns of T cell immunity to COVID-19.新冠病毒 T 细胞免疫的已知未知数。
Sci Immunol. 2020 Nov 18;5(53). doi: 10.1126/sciimmunol.abe8063.
7
The fragility of humoral immunity as a physiological safety marker for healthcare workers to return after COVID-19 convalescence.体液免疫作为医护人员新冠康复后返岗的生理安全标志物的脆弱性。
J Microbiol Immunol Infect. 2021 Feb;54(1):141-143. doi: 10.1016/j.jmii.2020.08.012. Epub 2020 Aug 19.
8
Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection.高通量测序分析 TCR 文库表明 SARS-CoV-2 感染后 T 细胞免疫反应的特征。
Cells. 2021 Dec 27;11(1):68. doi: 10.3390/cells11010068.
9
Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.康复期无症状或轻症至中度严重急性呼吸综合征冠状病毒 2 感染的医护人员体液和 T 细胞免疫进行性和并行下降。
J Infect Dis. 2021 Jul 15;224(2):241-245. doi: 10.1093/infdis/jiab242.
10
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.COVID-19 恢复期多发性硬化症患者对 SARS-CoV-2 的体液和细胞反应。
Neurol Neuroimmunol Neuroinflamm. 2022 Feb 1;9(2). doi: 10.1212/NXI.0000000000001143. Print 2022 Mar.

引用本文的文献

1
Development of monoclonal antibody-based blocking ELISA for detecting SARS-CoV-2 exposure in animals.基于单克隆抗体的阻断 ELISA 的开发，用于检测动物中 SARS-CoV-2 的暴露情况。
mSphere. 2023 Aug 24;8(4):e0006723. doi: 10.1128/msphere.00067-23. Epub 2023 Jul 6.
2
Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID-19 survivors.免疫受体测序揭示 COVID-19 幸存者的适应性免疫系统异常。
J Med Virol. 2023 Jan;95(1):e28340. doi: 10.1002/jmv.28340.
3
Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection.

本文引用的文献

1
Clinical Utility of In-house Metagenomic Next-generation Sequencing for the Diagnosis of Lower Respiratory Tract Infections and Analysis of the Host Immune Response.宏基因组下一代测序在诊断下呼吸道感染中的临床应用及宿主免疫反应分析。
Clin Infect Dis. 2020 Dec 23;71(Suppl 4):S416-S426. doi: 10.1093/cid/ciaa1516.
2
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma.早期复发肝细胞癌生态系统的单细胞景观。
Cell. 2021 Jan 21;184(2):404-421.e16. doi: 10.1016/j.cell.2020.11.041. Epub 2020 Dec 23.
3
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
自然感染新冠病毒后一年半，针对该病毒的中和抗体及细胞免疫反应依然存在。
Front Microbiol. 2022 Mar 3;12:803031. doi: 10.3389/fmicb.2021.803031. eCollection 2021.
4
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery - a comprehensive systematic review and meta-analysis.COVID-19 适应性免疫和康复后再感染的流行情况——一项全面的系统评价和荟萃分析。
Pathog Glob Health. 2022 Jul;116(5):269-281. doi: 10.1080/20477724.2022.2029301. Epub 2022 Jan 31.
5
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron.新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变异株奥密克戎的免疫逃逸能力增强。
Cell Mol Immunol. 2022 Feb;19(2):293-295. doi: 10.1038/s41423-021-00836-z. Epub 2022 Jan 11.
6
The way of SARS-CoV-2 vaccine development: success and challenges.SARS-CoV-2 疫苗的研发之路：成功与挑战。
Signal Transduct Target Ther. 2021 Nov 9;6(1):387. doi: 10.1038/s41392-021-00796-w.
7
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.一种非 RBM 靶向 RBD 特异性抗体中和 SARS-CoV-2 诱导 S1 脱落。
Biochem Biophys Res Commun. 2021 Sep 24;571:152-158. doi: 10.1016/j.bbrc.2021.07.062. Epub 2021 Jul 20.
8
A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter.基于含有单体近红外荧光蛋白作为报告分子的 SARS-CoV-2 假病毒的实时高通量中和试验。
Emerg Microbes Infect. 2021 Dec;10(1):894-904. doi: 10.1080/22221751.2021.1925163.
9
Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area.纽约都会区 2019 冠状病毒病康复期血浆捐献者和捐献的特点。
Transfusion. 2021 Aug;61(8):2374-2383. doi: 10.1111/trf.16421. Epub 2021 May 4.
10
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies.新出现的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体降低了对康复期血清和单克隆抗体的中和敏感性。
Cell Mol Immunol. 2021 Apr;18(4):1061-1063. doi: 10.1038/s41423-021-00648-1. Epub 2021 Feb 25.
羟氯喹对 COVID-19 住院患者 14 天临床状态的影响：一项随机临床试验。
JAMA. 2020 Dec 1;324(21):2165-2176. doi: 10.1001/jama.2020.22240.
4
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.正交 SARS-CoV-2 血清学检测可用于监测低流行社区，并揭示持久的体液免疫。
Immunity. 2020 Nov 17;53(5):925-933.e4. doi: 10.1016/j.immuni.2020.10.004. Epub 2020 Oct 14.
5
Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19).外科口罩分区降低了 2019 冠状病毒病（COVID-19）金黄地鼠模型中非接触传播的风险。
Clin Infect Dis. 2020 Nov 19;71(16):2139-2149. doi: 10.1093/cid/ciaa644.